We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

17 hedge funds and large institutions have $2.23M invested in Bio-Path Holdings Inc in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 17 → 17 (0)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

24% less capital invested

Capital invested by funds: $2.94M → $2.23M (-$718K)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$119K
2
TRCT
Tower Research Capital (TRC)
New York
+$7.2K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.52K
4
Northern Trust
Northern Trust
Illinois
+$2.16K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$77.7K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$76.5K
3
UBS Group
UBS Group
Switzerland
-$19.8K
4
BlackRock
BlackRock
New York
-$2.52K
5
Bank of America
Bank of America
North Carolina
-$360

BPTH Hedge Fund Activity: Q3 2021 in Review

17 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2021, worth a combined $2.23M — down 24% from $2.94M a quarter earlier.

Fund positioning in BPTH was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 5 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $119K. The largest seller was Citadel Advisors, cutting an estimated $77.7K.

  • 17 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $2.23M of Bio-Path Holdings Inc stock for Q3 2021, down 24% quarter-over-quarter.
  • 0 funds opened new Bio-Path Holdings Inc positions in Q3 2021 and 0 closed out.
  • The largest Bio-Path Holdings Inc buyer in Q3 2021 was Morgan Stanley, an estimated $119K added.
  • The largest Bio-Path Holdings Inc seller in Q3 2021 was Citadel Advisors, an estimated $77.7K sold.

Based on aggregated 13F filings for Q3 2021.